News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
883,789 Results
Type
Article (88776)
Company Profile (816)
Press Release (794174)
Multimedia
Podcasts (238)
Webinars (35)
Section
Business (233590)
Career Advice (4162)
Deals (39989)
Drug Delivery (177)
Drug Development (91702)
Employer Resources (207)
FDA (18553)
Job Trends (17486)
News (398729)
Policy (40013)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3053)
Academic (2)
Accelerated approval (56)
ADA (49)
Adcomms (40)
Allergies (196)
Alliances (56990)
ALS (236)
Alzheimer's disease (1967)
Antibody-drug conjugate (ADC) (551)
Approvals (18892)
Artificial intelligence (867)
ASCO (345)
Autoimmune disease (361)
Automation (64)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (248)
Biotechnology (480)
Bladder cancer (211)
Brain cancer (85)
Breast cancer (837)
Cancer (6568)
Cardiovascular disease (554)
Career advice (3597)
Career pathing (52)
CAR-T (384)
CDC (76)
Celiac Disease (3)
Cell therapy (1069)
Cervical cancer (54)
Clinical research (78995)
Collaboration (2366)
Company closure (8)
Compensation (1508)
Complete response letters (106)
COVID-19 (3041)
CRISPR (124)
C-suite (1282)
Cystic fibrosis (167)
Data (8678)
Decentralized trials (3)
Denatured (91)
Depression (193)
Dermatology (96)
Diabetes (703)
Diagnostics (7596)
Digital health (69)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (424)
Drug pricing (245)
Drug shortages (39)
Duchenne muscular dystrophy (318)
Earnings (102482)
Editorial (78)
Employer branding (25)
Employer resources (174)
Events (138644)
Executive appointments (1192)
FDA (22616)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (19)
Frontotemporal dementia (36)
Funding (1940)
Gene editing (270)
Generative AI (89)
Gene therapy (849)
GLP-1 (1284)
Government (5559)
Grass and pollen (8)
Guidances (419)
Healthcare (21260)
Hematology (198)
HIV (94)
Huntington's disease (64)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (115)
Immunology and inflammation (353)
Immuno-oncology (116)
Indications (206)
Infectious disease (3439)
Inflammatory bowel disease (242)
Inflation Reduction Act (17)
Influenza (148)
Intellectual property (322)
Interviews (821)
IPO (18002)
IRA (61)
Job creations (5209)
Job search strategy (2871)
JPM (73)
Kidney cancer (23)
Labor market (122)
Layoffs (686)
Leadership (53)
Legal (10171)
Liver cancer (111)
Longevity (37)
Lung cancer (873)
Lymphoma (465)
Machine learning (66)
Management (66)
Manufacturing (1220)
MASH (226)
Medical device (15276)
Medtech (15434)
Mergers & acquisitions (23285)
Metabolic disorders (1820)
mRNA (266)
Multiple sclerosis (204)
NASH (24)
Neurodegenerative disease (507)
Neuropsychiatric disorders (126)
Neuroscience (3712)
Neurotech (2)
NextGen: Class of 2026 (7716)
Non-profit (5145)
Now hiring (80)
Obesity (869)
Opinion (374)
Ovarian cancer (244)
Pain (285)
Pancreatic cancer (351)
Parkinson's disease (417)
Partnered (39)
Patents (654)
Patient recruitment (758)
Peanut (70)
People (67993)
Pharmaceutical (136)
Pharmacy benefit managers (37)
Phase 1 (24415)
Phase 2 (34309)
Phase 3 (25804)
Pipeline (9733)
Policy (397)
Postmarket research (3559)
Preclinical (10979)
Press Release (72)
Prostate cancer (347)
Psychedelics (68)
Radiopharmaceuticals (373)
Rare diseases (1261)
Real estate (7462)
Recruiting (81)
Regulatory (30380)
Reports (77)
Research institute (2771)
Resumes & cover letters (654)
Rett syndrome (42)
RNA editing (29)
RSV (98)
Schizophrenia (196)
Series A (327)
Series B (237)
Service/supplier (28)
Sickle cell disease (127)
Special edition (32)
Spinal muscular atrophy (190)
Sponsored (55)
Startups (4372)
State (2)
Stomach cancer (21)
Supply chain (146)
Tariffs (104)
The Weekly (144)
Vaccines (1306)
Venture capital (133)
Weight loss (597)
Women's health (141)
Worklife (24)
Date
Today (111)
Last 7 days (646)
Last 30 days (3271)
Last 365 days (33263)
2026 (16152)
2025 (33218)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1296)
Alabama (102)
Alaska (7)
Arizona (402)
Arkansas (16)
Asia (52293)
Australia (9192)
California (14364)
Canada (4012)
China (1570)
Colorado (618)
Connecticut (639)
Delaware (443)
Europe (120591)
Florida (2130)
Georgia (467)
Hawaii (4)
Idaho (70)
Illinois (1250)
India (102)
Indiana (663)
Iowa (25)
Japan (592)
Kansas (143)
Kentucky (56)
Louisiana (64)
Maine (89)
Maryland (1741)
Massachusetts (10509)
Michigan (422)
Minnesota (799)
Mississippi (7)
Missouri (164)
Montana (37)
Nebraska (30)
Nevada (153)
New Hampshire (92)
New Jersey (3809)
New Mexico (35)
New York (3778)
North Carolina (1937)
North Dakota (11)
Northern California (7140)
Ohio (449)
Oklahoma (27)
Oregon (55)
Pennsylvania (2831)
Puerto Rico (30)
Rhode Island (54)
South America (1668)
South Carolina (88)
South Dakota (2)
Southern California (5635)
Tennessee (227)
Texas (2341)
United States (51395)
Utah (426)
Vermont (1)
Virginia (363)
Washington D.C. (89)
Washington State (1179)
West Virginia (4)
Wisconsin (160)
Wyoming (2)
There are 883,789 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Paratus Sciences Presents Preclinical and Translational Data on PS-1001, a First-in-Class Pan-Inflammasome Inhibitor, at FOCIS 2026
June 11, 2026
·
3 min read
Press Releases
Sona Nanotech Appoints Seasoned Biotech Commercial Executive Michael A. Fleming to Board of Directors
June 11, 2026
·
4 min read
Press Releases
Bionano Announces Multiple Publications in 2026 Describing Unique Utility of OGM in Studies of Reproductive Health and Prenatal Genetic Disorders
June 11, 2026
·
9 min read
Press Releases
Rein Therapeutics Expands Phase 2 RENEW Trial into United Kingdom
June 11, 2026
·
4 min read
Press Releases
Loma Linda University Health and Nudj Health Launch Integrated Whole-Person Primary Care Model Designed to Advance the Future of Healthcare Delivery
June 11, 2026
·
7 min read
IPO
Sky-high Parabilis, Kailera IPOs spur optimism—but only for derisked biotechs
Biotechs are benefitting from the AI tech frenzy and inflation, but validated pipelines and careful planning are still key to the recent record-setting IPOs, experts say.
June 11, 2026
·
5 min read
·
Annalee Armstrong
Press Releases
ORYZON Presents Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia (AML) at European Hematology Association (EHA) 2026 Annual Congress
June 11, 2026
·
10 min read
Press Releases
OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted Infections
June 11, 2026
·
5 min read
Press Releases
Theriva™ Biologics Announces Results from VCN-01 Phase 1 Clinical Trial in Head and Neck Cancer Published in Clinical Cancer Research
June 11, 2026
·
8 min read
Immunology and inflammation
Takeda’s AI-designed pill bests BMS’ Sotyktu in head-to-head psoriasis trial
Takeda eyes an FDA run for its investigational psoriasis pill after the drug elicited total skin clearance in more than 35% of patients at 16 weeks—more than 2.5 times that in controls taking Bristol Myers Squibb’s Sotyktu.
June 11, 2026
·
1 min read
·
Tristan Manalac
1 of 88,379
Next
